Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. cancer specific
Show results for
Products

Companies

News
Articles

Refine by
Date

  • This Year
  • Older

Cancer Specific Articles & Analysis

28 articles found

Immortalized Human Ovarian Epithelial Cells-SV40: A Key Tool in Cancer Research

Immortalized Human Ovarian Epithelial Cells-SV40: A Key Tool in Cancer Research

Human ovarian epithelial cells play a crucial role in ovarian function and have become a significant focus in cancer research, specifically ovarian cancer. The ability to study these cells in a laboratory setting has been greatly enhanced through the development of immortalized human ovarian epithelial cell lines, particularly those that utilize ...

ByCreative Bioarray


Alfa Cytology Introduces Specialized Therapeutic Development Services Targeting FAP for Precision Oncology Treatments

Alfa Cytology Introduces Specialized Therapeutic Development Services Targeting FAP for Precision Oncology Treatments

Alfa Cytology has revealed new FAP-targeted therapeutics development services that aim to develop precise and effective cancer treatments. Alfa Cytology has introduced its groundbreaking initiative which targets fibroblast activation protein(FAP) for cancer therapies. ...

ByAlfa Cytology


Antibody Drug Design: Advancements and Innovations

Antibody Drug Design: Advancements and Innovations

In recent years, the field of antibody drug design has become increasingly significant in the realm of therapeutic development, driven by the need for more effective and targeted treatments for various diseases, including cancer, autoimmune disorders, and infectious diseases. Antibodies, which are proteins produced by the immune system, have the ability to ...

ByCreative Biogene


Advancing Cancer Treatment: The Role of Radioactive Drug Conjugate Development Services and Pre-Clinical Analysis Services for RDCs

Advancing Cancer Treatment: The Role of Radioactive Drug Conjugate Development Services and Pre-Clinical Analysis Services for RDCs

This specificity is achieved by linking a radioactive isotope to a monoclonal antibody or small molecule that targets specific cancer antigens. ...

ByAlfa Cytology


ADC Development and Production: Innovations and Best Practices

ADC Development and Production: Innovations and Best Practices

Antibody-Drug Conjugates (ADCs) represent a groundbreaking advancement in targeted cancer therapy, combining the specificity of antibodies with the potency of cytotoxic drugs. ...

ByCreative Biogene


Unveiling the Future of Leukemia: Advancements in Immunotherapy and Beyond 

Unveiling the Future of Leukemia: Advancements in Immunotherapy and Beyond 

Unlike conventional treatments that target both healthy and cancerous cells, immunotherapy empowers the body's immune system to recognize and combat cancer cells more selectively and effectively. ...

ByAlfa Cytology


Advancements in Breast Cancer Research: The Role of Tumor Models and Customized ADCs Development Services

Advancements in Breast Cancer Research: The Role of Tumor Models and Customized ADCs Development Services

Breast cancer remains one of the most prevalent malignancies affecting women worldwide, necessitating innovative approaches for effective treatment and research. ...

ByAlfa Cytology


Gene Delivery: A New Technology for Cancer Therapy

Gene Delivery: A New Technology for Cancer Therapy

By introducing a functional gene into the cells with these symptoms, researchers hope to correct the inherited gene mutation and potentially cure the disease. Gene delivery in cancer treatment involves the use of viral or non-viral vectors to deliver therapeutic genes into cancer cells. These approaches allow the targeted delivery of genes that can inhibit ...

ByCDBioSciences - VLPlant


Analysis of ADC Drug Biological Activity

Analysis of ADC Drug Biological Activity

This analysis is mainly based on the following aspects:1. Ensure Specificity and TargetingThe main advantage of ADC lies in its high specificity for specific cancer cell surface antigens. ...

ByMtoZ Biolabs


Comparison and Analysis of SMDC, ADC, and DAC

Comparison and Analysis of SMDC, ADC, and DAC

The antibody component specifically targets surface antigens on specific cancer cells, while the drug component is responsible for killing these bound cancer cells. ...

ByBOC Sciences


CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry

CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry

Immunohistochemistry is the study of the localization, characterization, and relative quantification of peptides and proteins in tissue cells using the antigen-antibody reaction, in which an antigen specifically binds to an antibody and a chemical reaction results in the visualization of dyes such as fluorescein and other chromogens, as well as enzymes, metal ions and isotopes, ...

ByCD BioSciences


Protein Engineering: Designing Molecular Machines for a Healthier Future

Protein Engineering: Designing Molecular Machines for a Healthier Future

For instance, engineered antibodies are being developed to target specific cancer cells with high precision, while engineered enzymes are being designed to break down harmful molecules in the body. Biotechnology and Industrial Applications: Protein engineering is playing an increasingly important role in industrial biotechnology, enabling the production of ...

ByCreative BioMart


Clinical Pharmacology of Antibody-Drug Conjugates

Clinical Pharmacology of Antibody-Drug Conjugates

In general, the incidence of ADA of ADCs is less in patients targeting hematologic cancer than in patients targeting solid cancer; Most ADA is specific to the monoclonal antibody domain of the ADC. ...

ByBOC Sciences


Array-based Methylation Detection Explores the Mysteries of Cancer

Array-based Methylation Detection Explores the Mysteries of Cancer

Microarray Analysis in Methylation Detection A number of hypomethylation intervals (hypomethylated blocks) are prevalent in multiple cancers. Ninety-five percent of the DNA methylation changes in cancer occur in those regions. ...

ByCD Genomics


Enhancing Oncology Model: New CMS value-based payment model aims to improve health equity and patient-centered care

Enhancing Oncology Model: New CMS value-based payment model aims to improve health equity and patient-centered care

Rolled out as part of the Biden-Harris Administration’s Cancer Moonshot, the goal of EOM is to improve the experience of cancer patients, while advancing health equity and increasing access to care, as well as reducing Medicare spending. ...

ByNavigating Cancer, Inc.


Mutation-directed Neo-protein-protein Interactions in Cancer

Mutation-directed Neo-protein-protein Interactions in Cancer

Professor Fu Haian's team at Emory University published a paper entitled: “Systematic discovery of mutation-directed neo-protein-protein interactions in cancer” online in Cell. In this study, they mapped the first draft neo-protein-protein interaction (neoPPI) network specific for common cancer gene mutations and found that the ...

ByProfacgen


The Barbara Ann Karmanos Cancer Center - Case study

The Barbara Ann Karmanos Cancer Center - Case study

The Barbara Ann Karmanos Cancer Center, located in midtown Detroit, is the only National Cancer Institute (NCI)-designated comprehensive cancer center in metro Detroit and one of just 51 centers of its kind in the United States. ...

ByAdvaita Bioinformatics


Antibody-peptide epitope conjugate (APEC), another disguise for ADC   

Antibody-peptide epitope conjugate (APEC), another disguise for ADC  

The researchers expose us to a radically different way of thinking in this article: instead of working on T cells, they focus on changing cancer cell antigens. They employed antibodies to deliver viral antigens to the tumor location and trigger virus-specific T lymphocytes to target cancer cells, destroying them. The corresponding author of ...

ByCreative Biolabs


Possible treatment of human multiple myeloma found

Possible treatment of human multiple myeloma found

In the study, the researchers propose a new method that mainly involves extensive screening of monoclonal antibodies against primary human tumor samples with the aim of identifying cancer-specific conformational epitopes throughout the protein that cannot be identified by transcriptome or proteome analysis. ...

ByProfacgen


Whatever Happens, the Patient Has to be at the Center

Whatever Happens, the Patient Has to be at the Center

In honor of World Cancer Day, we sat down with two Adapters to understand how their personal experiences with cancer intersect with their work at Adaptive. ...

ByAdaptive Biotechnologies

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT